Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 55 results for "Chronic Myeloid Leukemia (CML)".

Thumbnail for Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

CML - 596

Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Sepsis as a Major Driver of Mortality in Hospitalized Leukemia Patients: A National Inpatient Sample Analysis (2018-2023)

CML - 602

Sepsis as a Major Driver of Mortality in Hospitalized Leukemia Patients: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Treatment-Free Remission (TFR) for newly diagnosed Accelerated Phase Chronic Myeloid Leukemia (AP-CML)

Previous 1 2 3 4 5 6 7 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

CML - 603

Treatment-Free Remission (TFR) for newly diagnosed Accelerated Phase Chronic Myeloid Leukemia (AP-CML)

Fadi G Haddad

Poster Presenter: Fadi G Haddad

Thumbnail for ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

CML - 652

ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

Fadi G Haddad

Poster Presenter: Fadi G Haddad

Thumbnail for Overall Survival and Prognostic Factors in Atypical Chronic Myeloid Leukemia (BCR/ABL-negative): A SEER Population-Based Analysis (2000-2022)

CML - 653

Overall Survival and Prognostic Factors in Atypical Chronic Myeloid Leukemia (BCR/ABL-negative): A SEER Population-Based Analysis (2000-2022)

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Population-Based Survival Patterns and Future Disease Burden of Chronic MyelomonocyticLeukemia in the United States: A SEER Analysis

CML - 654

Population-Based Survival Patterns and Future Disease Burden of Chronic MyelomonocyticLeukemia in the United States: A SEER Analysis

Samhitha Gundakaram

Poster Presenter: Samhitha Gundakaram

Thumbnail for Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

CML - 692

Asciminib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP): A Retrospective Chart Review Study in the US

Ehab L Atallah

Poster Presenter: Ehab L Atallah

Thumbnail for Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CML - 694

Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Akriti G Jain

Poster Presenter: Akriti G Jain

Thumbnail for Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML

CML - 709

Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML

Umar Iqbal

Poster Presenter: Umar Iqbal

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors